Grunenthal Logo

External Link

You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.

Title
Description
Trial IDKF6005/02
CompoundCebranopadol
Trials sponsorGrünenthal GmbH
Trial phase2
Brief titlePainful Diabetic Polyneuropathy Trial With a New Centrally Acting Analgesic
IndicationDiabetic polyneuropathy, Diabetic neuropathy
UTN
CTG IDNCT00878293
CTIS ID (former EudraCT)2008-004794-18
Trial statusCompleted
FPIApril 15, 2009
LPOMay 25, 2010
CountriesGermany, United Kingdom
GenderAll
Age18 Years to 75 Years
ResultsYes
Pubmed
Documents
KF6005-02 | Grünenthal